Prescient Therapeutics Limited’s (PTX) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting Prescient Therapeutics Limited is a Sell.
Prescient Therapeutics Limited’s (PTX) 20-Day exponential moving average is 0.06, while Prescient Therapeutics Limited’s (PTX) share price is AU$0.06, making it a Buy.
Prescient Therapeutics Limited’s (PTX) 50-Day exponential moving average is 0.06, while Prescient Therapeutics Limited’s (PTX) share price is AU$0.06, making it a Sell.
Prescient Therapeutics Limited’s (PTX) 10-Day exponential moving average is 0.06, while Prescient Therapeutics Limited’s (PTX) share price is AU$0.06, making it a Buy.
Prescient Therapeutics Limited’s (PTX) 100-Day exponential moving average is 0.07, while Prescient Therapeutics Limited’s (PTX) share price is AU$0.06, making it a Sell.
Prescient Therapeutics Limited’s (PTX) stock price is AU$0.06 and Prescient Therapeutics Limited’s (PTX) 50-day simple moving average is 0.06, creating a Sell signal.
Prescient Therapeutics Limited’s (PTX) stock price is AU$0.06 and Prescient Therapeutics Limited’s (PTX) 100-day simple moving average is 0.07, creating a Sell signal.
Prescient Therapeutics Limited’s (PTX) stock price is AU$0.06 and Prescient Therapeutics Limited’s (PTX) 200-day simple moving average is 0.07, creating a Sell signal.